Dr. James F. Vander

Country:
Experience: Not Available
Hospital: Not Available

About

Dr. James Vander specializes in Ophthalmology, with a special focus on Diabetic Eye Disease/Retinopathy, Retinal Disorders and Macular Degeneration. He practices primarily in Philadelphia, PA, and is affiliated with Wills Eye Hospital. Dr. Vander graduated from University of Michigan Medical School in 1984, and completed his training at Univ Michigan Med Ctr and Wills Eye Hosp. He is board certified in Ophthalmology.

List of Treatments

Practice Locations

Mid Atlantic Retina
840 Walnut Street, Suite 1020Philadelphia, PA 19107

Mid Atlantic Retina
4060 Butler Pike, Suite 200Plymouth Meeting, PA 19462

Work Experience

  • Wills Eye Hospital is a global leader in the treatment of eye disease. Our clinical expertise, state-of-the-art diagnostic testing and advanced surgical capabilities make Wills Eye a worldwide referral center where more than 300,000 patients are treated annually. Today, we continue to shape the science and medicine of ophthalmology, thanks to our talented and skilled physicians and staff who are dedicated to improving and preserving sight.

  • Eye Emergency Department

    As the Philadelphia region’s only emergency eye care center, the Wills Eye Emergency Department is open 24/7, 365 days/year and provides state-of-the-art emergency eye care at our Center City location. Eye emergencies range from infections to trauma and, if untreated, can lead to visual loss or other health problems. We have expert eye doctors in all specialties at all times to manage eye emergencies.

Special Interest

Regional Guides

America’s Top Doctors (book series): 10th Edition, 11th Edition, 12th Edition, 13th Edition, 14th Edition, 6th Edition, 7th Edition, 8th Edition, 9th Edition

Philadelphia Magazine: 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023

Castle Connolly America’s Top Doctors (digital guide): 2016, 2017, 2018, 2019, 2020, 2021

Schneps Media – Philadelphia Metro: 2021